Erica discusses four technology areas that the healthcare network can embrace to increase speed to therapy, affordability, and adherence.
To learn more about CoverMyMeds' specialty medication access solutions, download their new whitepaper: Helping Patients Access Specialty Therapies: Autoimmune Conditions. (Free download)
Read on for Erica’s insights.
The Value of Patient-Centricity in Tech-Enabled Medication Access Solutions
By Erica Conroy, Ph.D., Vice President, Specialty, CoverMyMeds
Traditional hubs often rely on a fragmented landscape of disparate vendors to build a program. When multiple vendors connect through different systems, launch times are often delayed due to a program that’s not been tried and tested and a focus that’s strayed from building a patient-centered solution.
Often, the manufacturer is left to put the pieces together, leading to an equally fragmented patient experience, and, inevitability, a slower time to therapy for the patient.
With this type of model, not only is the patient’s journey to therapy more likely to be longer, it’s also likely taking effort to get from one point to the next with more than 70 touchpoints, like phone calls, the patient is left to initiate throughout their access journey.
While we all understand the importance of an effective workflow—and its impact on the patient journey—several factors still impede the patient’s experience to access, afford and, ultimately, adhere to their therapy.
Here, I focus on four technology areas the healthcare network can embrace to create a patient-centric solution that drives value to help patients access the medications they need.
1.) ENGAGING PROVIDERS WHERE THEY ARE
Leveraging a highly engaged network in one centralized platform has many benefits. First and foremost: Within a complex healthcare system, the provider serves as the closest advocate for the patient. Connecting with providers through an established network allows for increased patient reach — and reaching more patients enables access to the programs that support them on their therapy journey.
2.) PROVIDING THE RIGHT SERVICE AT THE RIGHT TIME
Something as simple as an in-workflow prompt can help improve a patient’s speed to therapy.
By engaging providers within the workflow they’re already using and familiar with, efficiency is maximized and they’re able to receive seamless navigation to the next required action to fulfill the patient journey.
By leveraging intelligent prompts, this intuitive user experience ensures the provider has the right information at the right time. When executed thoughtfully and strategically, prompts enable a provider to navigate access tasks more effectively — and get the patient on therapy faster.
3.) IMPROVING SPEED TO THERAPY
The impact of starting a patient’s access journey before gathering authorization can’t be overstated.
While a traditional hub model can take nearly four days to gather HIPAA authorization before benefits verification (BV) can begin, a patient-centric solution can complete BV in as little as one business day. Next, the prior authorization process can seamlessly begin — all while back-end support is working in parallel to gather patient authorization with no wasted time moving the patient through the initial access activities. This all occurs in the time it takes for the traditional model to capture consent.
4.) PEOPLE MAKE A DIFFERENCE
Today, technology is a given. But while many solutions are built on technology, our pride is in our people. Take AMP: Access for More Patients™, a technology-driven patient support solution that transforms how patients access, afford, and adhere to their medications.
AMP case managers are intentionally assigned to regions and cases to build a rapport with the patients they serve. This benefit allows the patient to interact with the same person each time. And ultimately, through a team of dedicated people, we’re able to assess patient sentiment and impact.
Additionally, as illustrated in our recent autoimmune whitepaper, AMP’s value lends the ability to support patient journey nuances required for different disease states and brands—no matter what the size or stage in the lifecycle. By creating value through a patient-centric solution, it can facilitate and automate access to improve the patient journey and accelerate their speed to therapy by as much as 34 percent in some cases.
Further, our partnership with RxCrossroads by McKesson combines the power of our solutions and brings a breadth of experience equating to expertise in more than 90 percent of therapeutic areas. Together, we have the ability to configure solutions and support to meet a brand’s specific needs – all through one offering.
Visit our website to learn how AMP can deliver value for your brand or read our new whitepaper Helping Patients Access Specialty Therapies: Autoimmune Conditions to learn how AMP can support patients within varying disease states.
Sponsored guest posts are bylined articles that are screened by Drug Channels to ensure a topical relevance to our exclusive audience. These posts do not necessarily reflect our opinions and should not be considered endorsements.
To find out how you can publish a guest post on Drug Channels, please contact Paula Fein (paula@DrugChannels.net).
No comments:
Post a Comment